rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2008-12-16
|
pubmed:databankReference |
|
pubmed:abstractText |
The neurokinin-1 receptor antagonist aprepitant, plus a 5HT3 antagonist and corticosteroid is well-tolerated and effective in preventing chemotherapy-induced nausea and vomiting in adults but has not been formally assessed in adolescents.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1545-5017
|
pubmed:author |
pubmed-author:Adolescent Aprepitant in Cancer Study Group,
pubmed-author:CaridesAlexandra DAD,
pubmed-author:ChawlaSantS,
pubmed-author:ChuaVickeyV,
pubmed-author:DevandrySuzanneS,
pubmed-author:EvansJudith KJK,
pubmed-author:GoreLiaL,
pubmed-author:HemenwayMollyM,
pubmed-author:OxeniusBettinaB,
pubmed-author:PetrilliAntonioA,
pubmed-author:SchisselDebraD,
pubmed-author:TaylorArleneA,
pubmed-author:ValentineJackJ
|
pubmed:copyrightInfo |
(c) 2008 Wiley-Liss, Inc.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
242-7
|
pubmed:dateRevised |
2009-10-21
|
pubmed:meshHeading |
pubmed-meshheading:18985740-Adolescent,
pubmed-meshheading:18985740-Antineoplastic Agents,
pubmed-meshheading:18985740-Area Under Curve,
pubmed-meshheading:18985740-Child,
pubmed-meshheading:18985740-Dexamethasone,
pubmed-meshheading:18985740-Double-Blind Method,
pubmed-meshheading:18985740-Drug Toxicity,
pubmed-meshheading:18985740-Humans,
pubmed-meshheading:18985740-Metabolic Clearance Rate,
pubmed-meshheading:18985740-Morpholines,
pubmed-meshheading:18985740-Nausea,
pubmed-meshheading:18985740-Neutropenia,
pubmed-meshheading:18985740-Ondansetron,
pubmed-meshheading:18985740-Placebos,
pubmed-meshheading:18985740-Treatment Outcome,
pubmed-meshheading:18985740-Vomiting,
pubmed-meshheading:18985740-Young Adult
|
pubmed:year |
2009
|
pubmed:articleTitle |
Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo-controlled study of efficacy and tolerability.
|
pubmed:affiliation |
Division of Pediatric Hematology/Oncology/Bone Marrow Transplant, Children's Hospital and The University of Colorado Denver, Aurora, Colorado, USA. lia.gore@ucdenver.edu
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|